|
LOC730101 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.65350000003173E-06 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.93254999999448E-05 |
| Normal-vs-Stage2 |
4.513800E-02 |
| Normal-vs-Stage3 |
1.912330E-02 |
| Normal-vs-Stage4 |
5.668000E-02 |
| Stage1-vs-Stage2 |
6.262400E-01 |
| Stage1-vs-Stage3 |
9.749200E-01 |
| Stage1-vs-Stage4 |
3.456400E-01 |
| Stage2-vs-Stage3 |
7.027200E-01 |
| Stage2-vs-Stage4 |
7.632800E-01 |
| Stage3-vs-Stage4 |
4.870200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.69929999960239E-07 |
| Normal-vs-AfricanAmerican |
4.053200E-01 |
| Normal-vs-Asian |
7.301600E-01 |
| Caucasian-vs-AfricanAmerican |
2.34209999999679E-05 |
| Caucasian-vs-Asian |
5.547200E-01 |
| AfricanAmerican-vs-Asian |
4.474200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
8.961700E-03 |
| Normal-vs-Female |
5.18380000036345E-07 |
| Male-vs-Female |
9.849000E-04 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.000000E-01 |
| Normal-vs-Age(41-60Yrs) |
1.122250E-02 |
| Normal-vs-Age(61-80Yrs) |
1.35400000000896E-06 |
| Normal-vs-Age(81-100Yrs) |
8.283600E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.585430E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.159640E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.871800E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.803400E-03 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.888400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.595600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
2.263400E-01 |
| Normal-vs-Grade 2 |
9.6600999999974E-05 |
| Normal-vs-Grade 3 |
1.016650E-04 |
| Normal-vs-Grade 4 |
4.074200E-01 |
| Grade 1-vs-Grade 2 |
3.984600E-01 |
| Grade 1-vs-Grade 3 |
5.409200E-01 |
| Grade 1-vs-Grade 4 |
5.848800E-01 |
| Grade 2-vs-Grade 3 |
6.670200E-01 |
| Grade 2-vs-Grade 4 |
2.531700E-02 |
| Grade 3-vs-Grade 4 |
4.605900E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
3.1435998248952E-10 |
| Normal-vs-ccB subtype |
7.485000E-01 |
| ccA subtype-vs-ccB subtype |
5.79519999766021E-08 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.017300E-04 |
| Normal-vs-N1 |
9.641800E-01 |
| N0-vs-N1 |
1.215180E-01 |
|
|
